IP Verse

Lixisenatide Synthesis With Capping

PatentPatent Analysis

EP3774838

SANOFI AVENTIS DEUTSCHLAND
Application Number
EP19715517A
Filing Date
Apr 10, 2019
Status
Granted And Under Opposition
Jul 8, 2022
Grant Date
Aug 10, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2788050B2
EP3307357B2
EP3153196B1

Bibliography

The patent EP3774838B1 was granted to Sanofi Aventis Deutschland on Aug 10, 2022 following the initial filing on Apr 10, 2019 under the application number EP19715517A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDMay 9, 2023ADMISSIBLE
FRESENIUS KABI DEUTSCHLANDMay 8, 2023ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents